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Introduction
Recently, humidified high flow nasal cannula oxygen
(HFNC) has gained popularity in treating patients with
respiratory insufficiency. Studies have shown that
HFNC generates a low level of positive airway pres-
sure, reduction of airway resistance and flushes naso-
pharyngeal dead space leading to less work of
breathing. We are using HFNC in a variety of patients
since 2010.
Objectives
We compared the outcomes of HFNC with conventional
oxygen therapy in different groups of ICU patients with
respiratory failure.
Methods
We retrospectively studied respiratory -, oxygen
derived- and hemodynamic parameters before and one
hour after start of HFNC in 116 patients during 2010
and 2011. All patients were treated in a mixed medical,
surgical, neurological ICU of a teaching hospital. We
compared non-invasive oxygen therapy like venturi
mask, non-rebreathing mask and non-invasive positive
pressure ventilation with HFNC. The HFNC used an
air-oxygen blender with adjustable Fi02 (0.21-1.0), deli-
vering a modifiable gas flow of 40 l/min (Optiflow,
Fisher&Paykel, Auckland, New Zeeland) in combina-
tion with humidification. Data from Metavi-
sionTMPDMS and MediscoreTM. We used oneway
ANOVA to compare hemodynamic and oxygen related
variables before and one hour after start of HFNC.
Results
116 patients were included, 66 men and 50 women,
mean age 66, SD 14, mean APACHE 4 on admission 64,
SD 21. Mean duration of HFNC was 24, SD 31 hours.
Indications for HFNC could be divided in 6 categories;
1. Hypoxia: n = 41, 2. Weaning from NPPV: n = 25, 3.
Comfort: n = 18, 4. No acceptance of non-invasive posi-
tive pressure ventilation (NPPV): n = 17, 5. Respiratory
distress/comfort: n = 9, 6. Other: n = 6. In 21 patients
we measured arterial blood gases (ABG). The oxygena-
tion was significant better with HFNC, Pa02 (p = 0,019)
and Pa02/Fi02 (p = 0,002). The PaC02 was significant
lower (p = 0,048) with HFNC. In 116 patients the per-
ipheral oxygen saturation (Sp02)/ fraction of inspired
oxygen (Fi02) ratio was significant better (p = 0,000)
with HFNC, the respiratory rate was significant lower
(p = 0,000) with HFNC. Also the hemodynamic vari-
ables heart rate and mean arterial pressure were signifi-
cant better with HFNC. Despite the use of HFNC, in 35
patients (30%) intubation was unavoidable and 29
patients (25%) died.
Conclusions
We used HFNC therapy for different indications. Oxy-
gen derived parameters significantly increased after one
hour of HFNC. Also respiratory rate, heart rate and
mean arterial pressure were significant better with
HFNC compared with conventional oxygen therapy.
HFNC was successful and well tolerated in patients
weaning from NPPV. HFNC is a useful and a comforta-
ble tool in oxygen therapy. There were no adverse
effects of HFNC. Further research is necessary to iden-
tify which flow rate is the best in different indications of
HFNC.
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